drugset / Trial / NCT04704739

Evaluation of Mass Balance and Absolute Bioavailability of GLPG1205

NCT04704739

Phase 1 Completed 12 enrolled Lakefront Biotherapeutics NV
Non-randomizedSequentialOpen-labelBasic science

Summary

A study in healthy male volunteers to assess how the radiolabelled test medicine is taken up and broken down by the body when given by short infusion into a vein and when given by the mouth in the form of a capsule or tablet.

Timeline

Start
2021-01-13
Primary completion
2021-03-02
Completion
2021-03-10

Drugs

EvaluationDrugModalityDoseRoute
Subject GLPG1205 Small molecule Oral

Indications

No indication recorded.